National Institute on Drug Dependence, China
7 clinical trials · Sponsor
◉ Watch National Institute on Drug Dependence, China
| Record | Firm | Date |
|---|---|---|
| Adjunctive Everolimus Treatment of Refractory Epilepsy (NCT05613166) | National Institute on Drug Dependence, China | 2022-11-01 |
| Neurocognitive Functions of Recovered COVID-19 Patients (NCT04622748) | National Institute on Drug Dependence, China | 2020-07-10 |
| MHealth Intervention of HIV and STDs Partner Notification for MSM (NCT04349748) | National Institute on Drug Dependence, China | 2020-07-01 |
Track National Institute on Drug Dependence, China automatically
Every clearance here is in the API, with alerts when new ones post.